Latest research, congress highlights, and guideline interpretations
Clinical reasoning and practical insights through real-world cases.
Original research and breakthroughs in digital healthcare.
Multidisciplinary application of diabetes products and services.
The 2026 ADA guidelines elevate continuous glucose monitoring (CGM) to a core tool for diabetes management, ushering in an era of dynamic blood glucose control. It puts forward five key updates: setting personalized glycemic targets combining HbA1c and CGM indicators, expanding CGM's applicable population, optimizing suggestions for special groups, enabling early warning of hypoglycemia via CGM, and stressing that education, stable supply and skin care are essential for effective CGM application.
This article covers the 2025 CLMC Conference, where Sinocare released a full-cycle digital cardio-diabetes co-management system. Targeting fragmented glucose and cardiac care, it integrates CGM, wearables and AI to build closed-loop monitoring-intervention workflows. Its iCan i6 Pro CGM enables 15-day pain-free continuous tracking, supporting personalized precision chronic disease management and real-world clinical research.